Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch
HIT Consultant
OCTOBER 17, 2021
In 2020, a digital research firm projected the global DTx market to hit nearly $9 billion by 2025; a year later, its 2025 DTx forecast had increased to $56 billion 2. The FDA designates DTx products as Software as Medical Device (SaMD), which, until recently, were considered Class I (low to moderate risk) devices.
Let's personalize your content